KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Equity Ratio (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Equity Ratio for 11 consecutive years, with 0.17 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Equity Ratio changed N/A year-over-year to 0.17, compared with a TTM value of 0.17 through Sep 2025, changed N/A, and an annual FY2024 reading of 0.39, up 16.48% over the prior year.
  • Equity Ratio was 0.17 for Q3 2025 at Medpace Holdings, down from 0.31 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.59 in Q1 2021 and bottomed at 0.17 in Q3 2025.
  • Average Equity Ratio over 5 years is 0.37, with a median of 0.34 recorded in 2023.
  • The sharpest move saw Equity Ratio crashed 62.85% in 2022, then surged 50.3% in 2024.
  • Year by year, Equity Ratio stood at 0.57 in 2021, then tumbled by 50.24% to 0.29 in 2022, then increased by 18.09% to 0.34 in 2023, then rose by 16.48% to 0.39 in 2024, then plummeted by 57.37% to 0.17 in 2025.
  • Business Quant data shows Equity Ratio for MEDP at 0.17 in Q3 2025, 0.31 in Q1 2025, and 0.39 in Q4 2024.